Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

NCT01308437 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

134

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Type I Diabetes

Interventions

BIOLOGICAL: Wosulin (N or 70/30 with R)
BIOLOGICAL: Novolin® (N or 70/30 with R)

Sponsor

Wockhardt